Diagnosis and treatment for complicated gastrointestinal stromal tumors.
- Author:
Lin CHEN
1
;
Licheng LIU
;
Wentong XU
Author Information
1. Department of General Surgery, The General Hospital of PLA, Beijing 100853, China. chenlinbj@vip.sina.com.
- Publication Type:Journal Article
- MeSH:
Gastrointestinal Neoplasms;
Gastrointestinal Stromal Tumors;
Humans;
Peritoneum;
Prognosis;
Protein Kinase Inhibitors
- From:
Chinese Journal of Gastrointestinal Surgery
2015;18(4):321-324
- CountryChina
- Language:Chinese
-
Abstract:
Tyrosine kinase inhibitor(TKI) combined with surgical treatment is the optimal strategy for gastrointestinal stromal tumors(GIST). However, there is no systemic report about the complicated GIST(recurrence or metastasis, peritoneal dissemination, combined resection of multiple organs), except the cases review and experimental studies. Tyrosine kinase inhibitor combined with surgery may increase the overall survival of complicated GIST. This article will describe the definition, clinical features, surgical and drug therapy, and prognosis, in order to provide reliable theoretical basis and experience for clinical doctors, prolong patient survival and improve the quality of survival.
